Overall rank by patents
#28,002
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F16F (SPRINGS; SHOCK-ABSORBERS; MEANS FOR DAMPING VIBRATION).
The verdict
Aisin holds 9 US patents across 10 technology areas, rank #28,002 of 50,000 tracked assignees.
Aisin Fukui Corporation has been granted 9 US utility patents between 2022 and 2025, placing Aisin Fukui Corporation at rank #28,002 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.6 claims per patent with primary concentration in F16F (SPRINGS; SHOCK-ABSORBERS; MEANS FOR DAMPING VIBRATION). As a Foreign Corporation, Aisin Fukui Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Aisin sits between AI Bioelectronic Healthtech Co., Ltd. (9 patents, rank #27,998) and Albemarle Europe SRL (9 patents, rank #28,006) - the closest US assignees by grant volume. The composite Innovation Score of 43.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Aisin Fukui Corporation's 7.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Aisin Fukui Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AI Bioelectronic Healthtech Co., Ltd.
9 patents
AIBLE INC.
9 patents
AICHI MACHINE INDUSTRY CO., LTD.
9 patents
AILNH, LLC
9 patents
AJ Innuscreen GmbH
9 patents
AKSIMO DISTRIBUTION LTD.
9 patents
AKWEL VIGO SPAIN S.L
9 patents
ALBEMARLE EUROPE SRL
9 patents
AISIN FUKUI CORPORATION
9 patents
What this shows Aisin holds 9 patents at rank #28,002, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,002 in granted patent volume.
Other assignees with the most granted patents in Aisin's primary technology class.
Aisin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 27% higher than 73% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 3 | 33.3% |
| 2024 | 3 | 33.3% |
| 2025 | 3 | 33.3% |
Top 10 of 10 technology areas
Overall rank by patents
#28,002
Across all tracked assignees
43.7 out of 100
How to use this portfolio
Aisin's 9 grants land it in the top 27% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.